Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Federal Judge Cuts Roundup Cancer Verdict, Agrees Monsanto Deserves Punishment

An $80 million verdict recently awarded to man who claimed Roundup herbicide caused his cancer was reduced to $25 million earlier this week, even though a federal judge in California agreed that Monsanto “deserved to be punished” for its “reprehensible … Continue reading

3M Military Earplugs Court Approves Protocol for “Technology Assisted Review”

Hundreds of lawsuits filed over allegedly defective military earplugs marketed by the 3M Company continue to move forward in the U.S. District Court, Northern District of Florida. According to a Pretrial Order dated July 1st, the Court has approved a … Continue reading

Bayer Loses Bid for New Trial in $80 Million Roundup Lawsuit

Bayer AG won’t be getting a do-over in the case of a California man who developed non-Hodgkin’s lymphoma following years of exposure to Monsanto Roundup. The company had sought a new trial in a bid to reverse the $80 million … Continue reading

Surgical Staplers Manufacturers Back FDA Reclassification Bid, But Wary of Special Controls

Two companies recently voiced approval for aU.S. Food & Drug Administration’s (FDA) proposal to reclassify internal surgical staplers as moderate risk medical devices However, Medtronic, Inc. and Johnson & Johnson also expressed concern over the agency’s plan to subject the … Continue reading

California Appeals Court Says Talcum Powder Lawsuit Plaintiff Deserves New Trial

The family of a California woman who died of ovarian cancer following decades of talcum powder use will have another chance for compensation, after an appeals court overturned part of a decision to dismiss her entire $417 million verdict. According … Continue reading

Gadolinium Deposits Shown to Accumulate in Brains of Early MS Patients

Researchers at the University of Buffalo have shown that gadolinium MRI contrast dyes can accumulate in the brain when administered to patients in the early stages of multiple sclerosis, or MS. While the gadolinium deposits did not appear to correlate … Continue reading

Takeda Faces New Uloric Heart Attack Lawsuit

Mark Gomez suffered a heart attack roughly two years after he began taking Uloric, Takeda Pharmaceutical’s controversial gout drug. According to a Uloric lawsuit recently filed on his behalf in the U.S. District Court, Northern District of Illinois, adequate safety … Continue reading

Parties in 3M Combat Arms Earplugs Lawsuits Push for Single-Track Litigation

Lawyers representing plaintiffs and defendants in hundreds of lawsuits involving the 3M Company’s Combat Arms Earplugs, Version 2, are urging a federal judge to allow individual personal injury claims and class action complaints to proceed on a single litigation track. … Continue reading

Monsanto Roundup Juror Defends $80 Million Glyphosate Cancer Verdict

A member of the jury that awarded $80 million to a California man who blamed Monsanto Roundup for his cancer has come forward to defend the panel’s decision. Glyphosate Cancer Verdict Included $75 Million in Punitive Damages Plaintiff Edward Hardeman, 77, … Continue reading

Gilead’s Truvada Donation Raises Suspicions of Patent Ploy

Gilead Sciences recently made news by promising to donate 2.5 million of bottles Truvada, one of the company’s blockbuster TDF-based HIV medications, to government efforts aimed at eradicating HIV and AIDS. While the Truvada donation would improve access among those … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content